The Multiple Sclerosis Foundation estimates that more than 400,000 people in the United States have been diagnosed with MS. There is no cure for multiple sclerosis (MS), but there are treatments available that can slow down its progression or treat symptoms.
The FDA recently approved a new option for relapsing forms of multiple sclerosis: Zinbryta (daclizumab).
Is there anything unique about Zinbryta?
Yes. Zinbryta is the first once-monthly injection for MS that you can give to yourself at home.
There are other treatments available that are also used monthly, but they can’t be self-administered; they must be given to you by a health care practitioner. Other treatments you can use at home must be taken more often.
What are the advantages to self-adminstered injections like Zinbryta?
Convenience. Self-administration allows you to take the medication at a time that is best for you.
Many other MS medications require an infusion at your doctor’s office. That means you have to spend not only the time and transportation to and from the office, but the time to receive the infusion.
How will Zinbryta be used?
The recommended dose of Zinbryta is a 150 mg injection once a month. You’ll inject the medication subcutaneously (into the skin) into a few approved areas, including thighs, stomach, and the back of your upper arms.
What are the side effects of Zinbryta?
The most common side effects associated with Zinbryta are upper respiratory tract infections (common cold), rash, flu, skin inflammation, throat pain, eczema, and swelling of the lymph nodes.
Want more information?